Page last updated: 2024-11-13

saikogenin f

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

saikogenin F: a saikosapogenin from roots of Bupleurium smithii var. parvifolium [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID21594261
CHEMBL ID3542345
SCHEMBL ID1046332
MeSH IDM0404975

Synonyms (9)

Synonym
saikogenin f
SCHEMBL1046332
CHEMBL3542345
14356-59-3
MS-28754
(1s,2s,4s,5r,8r,9r,10s,13s,14r,17s,18r)-9-(hydroxymethyl)-4,5,9,13,20,20-hexamethyl-24-oxahexacyclo[15.5.2.01,18.04,17.05,14.08,13]tetracos-15-ene-2,10-diol
CS-0135171
HY-N7670
AKOS040763726
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (13)

Assay IDTitleYearJournalArticle
AID1293539Cytotoxicity against human Hep3B cells after 48 hrs by MTT assay2016Bioorganic & medicinal chemistry letters, Mar-15, Volume: 26, Issue:6
Neuroprotective oleanane triterpenes from the roots of Bupleurum chinense.
AID1219349Drug level in Sprague-Dawley rat assessed as retention time treated with saikosaponin a by LC-DAD-IT-TOF-MS analysis2013Drug metabolism and disposition: the biological fate of chemicals, Mar, Volume: 41, Issue:3
Metabolism of saikosaponin a in rats: diverse oxidations on the aglycone moiety in liver and intestine in addition to hydrolysis of glycosidic bonds.
AID1293535Neuroprotective activity against H2O2-induced neuronal cell death in human SH-SY5Y cells assessed as cell viability at 50 uM pretreated for 12 hrs followed by H2O2 addition measured after 3 hrs by MTT assay relative to control2016Bioorganic & medicinal chemistry letters, Mar-15, Volume: 26, Issue:6
Neuroprotective oleanane triterpenes from the roots of Bupleurum chinense.
AID1293541Cytotoxicity against human MCF7 cells after 48 hrs by MTT assay2016Bioorganic & medicinal chemistry letters, Mar-15, Volume: 26, Issue:6
Neuroprotective oleanane triterpenes from the roots of Bupleurum chinense.
AID1293536Neuroprotective activity against H2O2-induced neuronal cell death in human SH-SY5Y cells assessed as cell viability at 25 uM pretreated for 12 hrs followed by H2O2 addition measured after 3 hrs by MTT assay relative to control2016Bioorganic & medicinal chemistry letters, Mar-15, Volume: 26, Issue:6
Neuroprotective oleanane triterpenes from the roots of Bupleurum chinense.
AID1219343Drug excretion in Sprague-Dawley rat feces treated with saikosaponin a at 15 mg/kg, iv by LC-DAD-IT-TOF-MS analysis2013Drug metabolism and disposition: the biological fate of chemicals, Mar, Volume: 41, Issue:3
Metabolism of saikosaponin a in rats: diverse oxidations on the aglycone moiety in liver and intestine in addition to hydrolysis of glycosidic bonds.
AID1293542Neuroprotective activity against H2O2-induced neuronal cell death in human SH-SY5Y cells assessed as cell viability at 100 uM pretreated for 12 hrs followed by H2O2 addition measured after 3 hrs by MTT assay relative to control2016Bioorganic & medicinal chemistry letters, Mar-15, Volume: 26, Issue:6
Neuroprotective oleanane triterpenes from the roots of Bupleurum chinense.
AID1293540Cytotoxicity against human Bcap37 cells after 48 hrs by MTT assay2016Bioorganic & medicinal chemistry letters, Mar-15, Volume: 26, Issue:6
Neuroprotective oleanane triterpenes from the roots of Bupleurum chinense.
AID1219347Drug excretion in Sprague-Dawley rat feces treated with saikosaponin a at 50 mg/kg, po administered through gavage by LC-DAD-IT-TOF-MS analysis2013Drug metabolism and disposition: the biological fate of chemicals, Mar, Volume: 41, Issue:3
Metabolism of saikosaponin a in rats: diverse oxidations on the aglycone moiety in liver and intestine in addition to hydrolysis of glycosidic bonds.
AID1293538Cytotoxicity against human HepG2 cells after 48 hrs by MTT assay2016Bioorganic & medicinal chemistry letters, Mar-15, Volume: 26, Issue:6
Neuroprotective oleanane triterpenes from the roots of Bupleurum chinense.
AID1293537Cytotoxicity against human A549 cells after 48 hrs by MTT assay2016Bioorganic & medicinal chemistry letters, Mar-15, Volume: 26, Issue:6
Neuroprotective oleanane triterpenes from the roots of Bupleurum chinense.
AID1219350Drug recovery in po dosed rat excreted feces measured over 0 to 24 hrs after drug administration by HPLC analysis relative to starting drug dose2013Drug metabolism and disposition: the biological fate of chemicals, Mar, Volume: 41, Issue:3
Metabolism of saikosaponin a in rats: diverse oxidations on the aglycone moiety in liver and intestine in addition to hydrolysis of glycosidic bonds.
AID1219311Drug excretion in Sprague-Dawley rat urine treated with saikosaponin a at 50 mg/kg, po administered through gavage by LC-DAD-IT-TOF-MS analysis2013Drug metabolism and disposition: the biological fate of chemicals, Mar, Volume: 41, Issue:3
Metabolism of saikosaponin a in rats: diverse oxidations on the aglycone moiety in liver and intestine in addition to hydrolysis of glycosidic bonds.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (7)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's1 (14.29)18.2507
2000's1 (14.29)29.6817
2010's3 (42.86)24.3611
2020's2 (28.57)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 12.98

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index12.98 (24.57)
Research Supply Index2.08 (2.92)
Research Growth Index5.06 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (12.98)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other7 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]